170 related articles for article (PubMed ID: 14555562)
21. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients.
Michils A; Baldassarre S; Van Muylem A
Eur Respir J; 2008 Mar; 31(3):539-46. PubMed ID: 18057062
[TBL] [Abstract][Full Text] [Related]
22. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.
Li AM; Tsang TW; Lam HS; Sung RY; Chang AB
Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863
[TBL] [Abstract][Full Text] [Related]
23. Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
van den Berge M; Luijk B; Bareille P; Dallow N; Postma DS; Lammers JW
Allergy; 2010 Dec; 65(12):1531-5. PubMed ID: 20560909
[TBL] [Abstract][Full Text] [Related]
24. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
25. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children.
Lanz MJ; Leung DY; White CW
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):161-4. PubMed ID: 10071519
[TBL] [Abstract][Full Text] [Related]
26. Perception of airway narrowing during reduction of inhaled corticosteroids and asthma exacerbation.
Salome CM; Leuppi JD; Freed R; Marks GB
Thorax; 2003 Dec; 58(12):1042-7. PubMed ID: 14645970
[TBL] [Abstract][Full Text] [Related]
27. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[TBL] [Abstract][Full Text] [Related]
28. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients.
Silkoff PE; McClean P; Spino M; Erlich L; Slutsky AS; Zamel N
Chest; 2001 May; 119(5):1322-8. PubMed ID: 11348935
[TBL] [Abstract][Full Text] [Related]
29. Assessing Inhaled Corticosteroid Adherence and Responsiveness in Severe Asthma Using Beclometasone Dipropionate/Formoterol NEXThaler Dose-Counting and Nitric Oxide Monitoring.
Aung HWW; Boddy CE; Hampson E; Bell M; Parnell LA; Balasundaram K; Murphy AC; Naveed S; Bradding P
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1539-1546.e5. PubMed ID: 38518866
[TBL] [Abstract][Full Text] [Related]
30. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults.
Aziz I; Wilson AM; Lipworth BJ
Chest; 2000 Oct; 118(4):1049-58. PubMed ID: 11035676
[TBL] [Abstract][Full Text] [Related]
31. Relationship between exhaled nitric oxide levels and compliance with inhaled corticosteroids in asthmatic children.
Katsara M; Donnelly D; Iqbal S; Elliott T; Everard ML
Respir Med; 2006 Sep; 100(9):1512-7. PubMed ID: 16504494
[TBL] [Abstract][Full Text] [Related]
32. Persistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthma.
Hirano T; Matsunaga K; Sugiura H; Minakata Y; Koarai A; Akamatsu K; Ichikawa T; Furukawa K; Ichinose M
Respir Investig; 2013 Jun; 51(2):84-91. PubMed ID: 23790736
[TBL] [Abstract][Full Text] [Related]
33. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
34. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
[TBL] [Abstract][Full Text] [Related]
35. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
Gelb AF; Flynn Taylor C; Shinar CM; Gutierrez C; Zamel N
Chest; 2006 Jun; 129(6):1492-9. PubMed ID: 16778266
[TBL] [Abstract][Full Text] [Related]
36. Exhaled nitric oxide levels and airway responsiveness to adenosine 5'-monophosphate in subjects with nasal polyposis.
Prieto L; Seijas T; Gutiérrez V; Uixera S; Bruno L; López R
Int Arch Allergy Immunol; 2004 Aug; 134(4):303-9. PubMed ID: 15205562
[TBL] [Abstract][Full Text] [Related]
37. Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function.
Ansarin K; Chatkin JM; Ferreira IM; Gutierrez CA; Zamel N; Chapman KR
Eur Respir J; 2001 May; 17(5):934-8. PubMed ID: 11488329
[TBL] [Abstract][Full Text] [Related]
38. Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects.
Prieto L; Gutiérrez V; Torres V; Uixera S; Marín J
Chest; 2002 Sep; 122(3):798-805. PubMed ID: 12226016
[TBL] [Abstract][Full Text] [Related]
39. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
[TBL] [Abstract][Full Text] [Related]
40. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.
Anderson WJ; Short PM; Williamson PA; Lipworth BJ
Chest; 2012 Dec; 142(6):1553-1561. PubMed ID: 23364390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
